Menichella Daniel L 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Sep 1, 2010
Insider Transaction Report
Form 4
Menichella Daniel L
Sr. VP, Business Development
Transactions
- Exercise/Conversion
Common Stock
2010-08-30$11.00/sh+100,000$1,100,000→ 117,013 total - Exercise/Conversion
Options (right to buy)
2010-08-30$11.00/sh−100,000$1,100,000→ 20,000 totalExercise: $11.00From: 2009-04-01Exp: 2018-04-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2010.
- [F2]Includes a grant by the Issuer to the Reporting Person of 5,921 options to purchase the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.